DNMT3A in haematological malignancies

L Yang, R Rau, MA Goodell - Nature Reviews Cancer, 2015 - nature.com
DNA methylation patterns are disrupted in various malignancies, suggesting a role in the
development of cancer, but genetic aberrations directly linking the DNA methylation …

DNMT3A in Leukemia

L Brunetti, MC Gundry… - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
DNA methylation is an epigenetic process involved in development, aging, and cancer.
Although the advent of new molecular techniques has enhanced our knowledge of how …

[HTML][HTML] Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies

CB Cole, DA Russler-Germain, S Ketkar… - The Journal of …, 2017 - Am Soc Clin Investig
The gene that encodes de novo DNA methyltransferase 3A (DNMT3A) is frequently mutated
in acute myeloid leukemia genomes. Point mutations at position R882 have been shown to …

A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells

SJ Kim, H Zhao, S Hardikar, AK Singh… - Blood, The Journal …, 2013 - ashpublications.org
Somatic heterozygous mutations of the DNA methyltransferase gene DNMT3A occur
frequently in acute myeloid leukemia and other hematological malignancies, with the …

[HTML][HTML] Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by …

JE Sandoval, YH Huang, A Muise, MA Goodell… - Journal of Biological …, 2019 - ASBMB
Eukaryotic DNA methylation prevents genomic instability by regulating the expression of
oncogenes and tumor-suppressor genes. The negative effects of dysregulated DNA …

DNA methyltransferases in hematological malignancies

NM Hoang, L Rui - Journal of Genetics and Genomics, 2020 - Elsevier
DNA methyltransferases (DNMTs) are an evolutionarily conserved family of DNA
methylases, transferring a methyl group onto the fifth carbon of a cytosine residue. The …

[HTML][HTML] Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation

C Holz-Schietinger, DM Matje, NO Reich - Journal of Biological Chemistry, 2012 - ASBMB
DNA methylation is a key regulator of gene expression and changes in DNA methylation
occur early in tumorigenesis. Mutations in the de novo DNA methyltransferase gene …

DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells

J Xu, YY Wang, YJ Dai, W Zhang… - Proceedings of the …, 2014 - National Acad Sciences
The gene encoding DNA methyltransferase 3A (DNMT3A) is mutated in∼ 20% of acute
myeloid leukemia cases, with Arg882 (R882) as the hotspot. Here, we addressed the …

Structural basis for DNMT3A-mediated de novo DNA methylation

ZM Zhang, R Lu, P Wang, Y Yu, D Chen, L Gao, S Liu… - Nature, 2018 - nature.com
DNA methylation by de novo DNA methyltransferases 3A (DNMT3A) and 3B (DNMT3B) at
cytosines is essential for genome regulation and development,. Dysregulation of this …

[HTML][HTML] CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression

DH Spencer, DA Russler-Germain, S Ketkar… - Cell, 2017 - cell.com
DNMT3A mutations occur in∼ 25% of acute myeloid leukemia (AML) patients. The most
common mutation, DNMT3A R882H, has dominant negative activity that reduces DNA …